Last updated on April 24, 2014 at 1:21 EDT

Drug Device Combination Products Market is Expected to Reach USD 115.1 Billion Globally in 2019: Transparency Market Research

December 24, 2013

NEW YORK, December 24, 2013 /PRNewswire/ –

According to a new market report published by Transparency Market Research “Drug
Device Combination Products Market (Drug Eluting Stents, Infusion Pumps, Photosensitizers,
Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal
Patches, Intraocular Implants and Drug Eluting Beads)- Global Industry Analysis, Size,
Share, Growth, Trends and Forecast, 2013 – 2019,” the global drug device combination
productsmarket was valued at USD 66.0 billion in 2012 and is expected to grow at a CAGR of
7.9% from 2013 to 2019, to reach an estimated value of USD 115.1 billion in 2019.

Browse the full report with complete TOC at


Drug device combination products are therapeutic products that combine a drug and a
medical device chemically and/or physically, to beproduced as a single product. These
products can be designed for local as well as systemic drug delivery.With the advances in
medical technology, medical devices have changed their definition to more complex devices
which assist in improving the efficiency of drugs in therapeutic treatments. These
innovations have also made it difficult for regulatory agencies to classify and provide
guidelines for safety and validation of these products.Newer developments in drug device
combination products have yielded several products for targeted drug delivery within the
body. Clinical trials for drug device combination products are more comprehensive and
expensive coupled with complications as compared to those required for individual drug and

Growing elderly population combined with rise in risk for cardiovascular diseases,
asthma and various other chronic disorders contribute to the growth of this market
particularly in emerging economies of Middle East, India and China. Moreover,
technological advancessuch as biodegradable implants coupled with increase in access and
recognition of these technologies in emerging market, will serve as an opportunity for
investors to invest in.

The global market for drug device combination products has been studied from the
perspective of current widely used various product types.The report provides a detailed
analysis of drug eluting stents which are segmented into coronary stents and peripheral
vascular stents while the infusion pumps include implantable infusion pumps and ambulatory
infusion pumps. Inhalers include metered dose inhalers, dry powder inhalers and
nebulizers. The others segment comprises intraocular implants and drug eluting beads. The
market estimations for transdermal patches, orthopedic combination products such as bone
graft implants and antibiotic loaded bone cements, wound care combination products and
photosensitizers have also been provided in the report for the forecast period 2013-2019.

The overall market for drug device combination products is fragmented owing to number
of small players involved in respective product segments. In 2012, transdermal patches
accounted for the largest share by revenue at USD 25.1 billion of the total drug device
combination products market. However, due to the product recalls and consequent stringent
regulatory approval procedures, the overall market revenue is expected to decline during
the forecast period in the U.S and Europe.The market for inhalers accounted for the second
largest share at over USD 20billion in 2012. It is estimated that the global market for
inhalers will grow at a CAGR of over 8% from 2013 to 2019, owing to its high incidence
rates of asthmatic and chronic obstructive pulmonary disease (COPD) patients.

Geographically, North America dominatedthe global market for drug device combination
products in terms of revenue generation and is expected to maintain its position
throughout the forecast period. Theadoption of drug eluting stents, implants, growing
elderly population and rise in incidences of hypertension and obesity in the U.S., is
expected to contribute to the leadership of the North American market. Europe was the
second largest regional market for drug device combination productsin 2012, owing to the
increased demand for drug eluting stents and infusion pumps.

Related & Recently Published Reports by Transparency Market Research

Coal Fired Power Generation Market:


Amines Market: http://www.transparencymarketresearch.com/amines-market.html

Teleradiology Market:


Orthobiologics Market:


The global drug device combination products market is dominated by few major players
including Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Inc.,
CareFusion Corporation and Allergen, Inc.

The global drug device combination products marketis segmented as follows:

Drug Device Combination Products Market, by Product Type

        - Drug Eluting Stents
             - Coronary Stents
             - Peripheral Vascular Stents
        - Infusion Pumps
             - Implantable Infusion Pumps
             - Ambulatory Infusion Pumps
        - Photosensitizers
        - Orthopedic Combination Products
             - Bone Graft Implants
             - Antibiotic Loaded Bone Cement
        - Wound Care Combination Products
        - Inhalers
             - Metered Dose Inhalers
             - Dry Powder Inhalers
             - Nebulizers
        - Transdermal Patches
        - Others
             - Intraocular Implants
             - Drug Eluting Beads

Drug Device Combination Products, by Geography

        - North America
        - Europe
        - Asia-Pacific
        - Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @


About Us

Transparency Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative forecasting
and trends analysis provides forward-looking insight for thousands of decision makers. We
are privileged with highly experienced team of Analysts, Researchers, and Consultants, who
use proprietary data sources and various tools and techniques to gather, and analyze

Our data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material for business


        Sheela AK
        90 Sate Street, Suite 700
        Albany, NY 12207
        Tel: +1-518-618-1030
        USA - Canada Toll Free: 866-552-3453
        Email: sales@transparencymarketresearch.com
        Web: http://www.transparencymarketresearch.com
        Blog: http://www.tmrblog.com
        Blog: http://www.culrav.org/pr/author/tmrrelease

SOURCE http://www.transparencymarketresearch.com/

Source: PR Newswire